Partner with us

Register

Sign In

Register now

Russell
Hanson
Chief Innovation Officer
Sama Therapeutics
Russell Hanson is a scientist and executive at the intersection of AI, healthcare, and biotechnology. As Chief Innovation Officer at Sama Therapeutics, he leads iMAGiNE, a GenAI platform for neuropsychiatry that supports drug discovery, diagnostics, and clinical decision-making. He has co-founded multiple AI and biotech companies, overseen successful exits, and advised on $100M+ transactions. Russell’s work spans AI drug discovery, neurodegenerative diseases, biosensors, and more, with publications in top scientific journals. A frequent keynote speaker, his mission is to harness AI, chemistry, and synthetic biology to drive global health innovation and improve patient outcomes through data-driven, validated technologies.
Button
29 May 2025 12:15 - 12:45
LLMs in healthcare: Operationalizing AI for clinical context and patient outcomes
LLMs are opening new frontiers in healthcare, from summarizing unstructured patient records to enhancing decision support and care coordination. But applying these models in clinical environments requires more than accuracy; it demands precision, context-awareness, and rigorous operational oversight. This session explores how healthcare teams are deploying LLMs in real workflows, with a focus on: → Extracting and structuring clinical insights from messy, unstructured data. → Mitigating risks around hallucinations, bias, and patient safety. →Integrating models into systems that drive measurable improvements in care. Whether you're working on model deployment, healthcare tooling, or data infrastructure, this session offers practical lessons for bringing LLMs from the lab to the clinic.

Useful links
link
Useful links
made with Acara
Social media